The use of multivitamin injections for vitamin supplementation and erythropoietin injections for neonatal anemia were associated with a higher likelihood of polysorbate 80 use, responsible for 59 (51.3%) and 37 (32.2%) of 115 polysorbate 80-containing prescriptions, respectively. The gene discussed is EPO; the disease is anemia.